| Ibrance | Verzenio |
|---|
| Ibrance(palbociclib) | Verzenio(abemaciclib) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prescription only Ibrance is a CDK4/6 inhibitor that may be used to treat advanced or metastatic hormone-receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer in combination...View more | Prescription only Verzenio (abemaciclib) is a targeted treatment that helps to reduce the growth and spread of cancer cells in the body. It may be used to treat HR+ HER2-, node-positive, early breast cancer at high...View more | Related suggestions | |||||||||||||||
| More aboutIbrance(palbociclib) | More aboutVerzenio(abemaciclib) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
Ibrance has an average rating of6.7 out of 10 from a total of82 ratings on Drugs.com.62% of reviewers reported a positive effect, while 30% reported a negative effect. | Verzenio has an average rating of8.0 out of 10 from a total of19 ratings on Drugs.com.63% of reviewers reported a positive effect, while 5% reported a negative effect. | ||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
See also: Ibrance side effects in more detail. | See also: Verzenio side effects in more detail. | ||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons* Prices are without insurance | |||||||||||||||||
View all Ibrance prices |
View all Verzenio prices | ||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
| ||||||||||||||||
| Brand Names | |||||||||||||||||
N/A | N/A | ||||||||||||||||
| Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
29 hours | 24.8 hours | ||||||||||||||||
| CSA Schedule **View glossary of terms | |||||||||||||||||
N Not a controlled drug Is not subject to the Controlled Substances Act. | N Not a controlled drug Is not subject to the Controlled Substances Act. | ||||||||||||||||
| Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. | Summary unavailable. See the full pregnancy warnings document. | ||||||||||||||||
| Drug Interactions | |||||||||||||||||
A total of 455 drugs are known to interact with Ibrance:
| A total of 301 drugs are known to interact with Verzenio:
| ||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
| ||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
| February 03, 2015 | September 28, 2017 | ||||||||||||||||
| WADA ClassView World Anti-Doping Agency classifications. | |||||||||||||||||
N/A | N/A | ||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circ*mstances.
